Amsterdam University Medical Centers, location AMC
Yvo Roos is professor of acute neurology, vice-head of the department of neurology and vice-chairman of the head and neck division in the Amsterdam University Medical Center. He was founder of the Acute Brain Care Unit (ABC-Unit) in 1996 which served as a blueprint for acute stroke care management, including CT-scanning and thrombolysis, in the Netherlands. He was Co-PI of the MRCLEAN trial; Co-PI of the MRCLEAN Registry; PI of the MRCLEAN No-IV within the CONTRAST consortium; executive committee member of HERMES, pooling 7 RCT’s on endovascular treatment of acute ischemic stroke; Co-PI of DIRECT MT trial. He is Chairman of StrokeNet (regional stroke care optimization) and Research leader of the Dutch Heart Foundation-funded ‘Circulating Nano Traces to Identify the Cause of Stroke’ (CINTICS), a research collaboration of the University of Amsterdam, Delft University of Technology, the University of Leiden and the Erasmus University Rotterdam. With the MRCLEAN co-PI’s he has won several prestigious prizes and awards – i.e. the Science and Innovation Award from the Dutch Federation of Medical Specialists and the Excellence and Innovation Award CIRSE (2017). In 2020 they won the Winkler Medal of the Dutch Neurology Society. He has (co-)authored over 350 papers (H-index of 56).
University of South Florida
David Z. Rose, M.D. is Associate Professor of Vascular Neurology at the University of South Florida (USF), and co-director of the 32-bed Neuro-ICU at Tampa General Hospital. Dr. Rose graduated from Stroke Fellowship at the University of Pennsylvania in Philadelphia, from Neurology Residency at the University of Miami’s Jackson Memorial Hospital, and from Internal Medicine Residency at the Cleveland Clinic in Ohio. Research interests include early use of Direct Oral Anticoagulants (DOAC) in Stroke with Atrial Fibrillation (AF), incidence of dementia in AF clinics and alternate options to anticoagulation such as Left Atrial Appendage Closure/Occlusion, Hypertension management for Intracerebral Hemorrhage, Synthetic Cannabis “Spice” associated with neurologic syndromes, and stroke simulation education with neuro-mnemonics. In 2014, he co-authored a fun review book "Laughing Your Way to Passing the Neurology Boards."
Massachusetts General Hospital
Dr. Natalia S. Rost, MD, MPH is Chief of Stroke Division at the Massachusetts General Hospital Department of Neurology and Professor of Neurology at Harvard Medical School. She is a clinician-scientist and international expert on neuroimaging markers of cerebrovascular disease, stroke genetics, and big data science for outcome prediction in patients with acute stroke. Rost is currently the MGH Research Scholar and Principal Investigator of DISCOVERY, a new national clinical research network funded by the NIH to address post-stroke cognitive impairment/dementia in the diverse US populations. Rost is the author of numerous peer-reviewed publications, book chapters, and co-author of the MGH Handbook of Neurology. She is the recipient of the 2012 Michael S. Pessin Stroke Leadership Award from the American Academy of Neurology and 2017 MGH Neurology Department’s Ray Adams Clinical Mentor Award. Dr. Rost serves as Associate Editor of the journal Stroke and Chair of the AAN’s Science Committee.
University of Oxford
Wolfson Centre for Prevention of Stroke and Dementia, Nuffield Department of Medicine
Peter Rothwell is the Action Research Professor of Neurology at Oxford University and Founding Director of the Wolfson Centre for Prevention of Stroke and Dementia (CPSD). His research group, which includes about 40 staff, studies the causes of stroke and strategies for improving prevention. Rothwell has published over 500 research papers and has been the recipient of many awards, including the Queen’s Anniversary Prize for Higher and Further Education.
Hospital Clínic of Barcelona
Comprehensive Stroke Center
Dr Salvatore Rudilosso is a stroke neurologist from the Hospital Clinic of Barcelona, and a fellow member of the ESO and WSO. His main fields of research are small vessel disease (SVD) and management of acute stroke. He completed his PhD program studying the hemodynamic perfusion patterns on CT perfusion in recent small subcortical infarcts (AJNR 2015; JCBFM 2019) and he is especially interested in studying SVD underlying mechanisms and clinical implications. To broaden his knowledge in the field of SVD, he completed a 6-month mobility research program grant at the Centre for Clinical Brain Sciences of the University of Edinburgh and participated in the recent ESO Guidelines on covert SVD (ESJ 2021). Dr Rudilosso also studied the usefulness of CT perfusion in assessing stroke mimics (Stroke 2020) and collaborated extensively in other studies focused on CT perfusion use. Dr Rudilosso has participated as an investigator in several RCTs of mechanical thrombectomy, secondary prevention in stroke and other collaborative works. He studied the prognostic value of neurologic improvement in patients treated with mechanical thrombectomy (Stroke 2019, JNIS 2020) and the efficacy of mechanical thrombectomy according to different prognostic profiles at baseline in a large population-based registry (accepted in JOS 2021).